Cite
HARVARD Citation
Robison, N. et al. (n.d.). LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study. Neuro-oncology. pp. i191-i192. [Online].